Citeline places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge and insight, by providing the perfect combination of news and information together with penetrating insight and analysis. Citeline is a leader in the field of healthcare industry information.
…
continue reading
In Plain Cite is a podcast about developments in federal criminal defense law, focusing on the US Supreme Court and the Fourth Circuit Court of Appeals, produced by the Federal Public Defender Office in the Southern District of West Virginia.
…
continue reading
Église chrétienne | Christian church
…
continue reading
Experts shape our world. Sometimes for better, sometimes for worse. In every big story, you’ll find one; you’ll find a researcher, scientist, engineer, planner, policy wonk, data nerd, bureaucrat, regulator, intellectual, or pseudo-intellectual. Their ideas are often opaque, unrecognized, and difficult to understand. Some of them like it that way. On Cited, we reveal their hidden stories.
…
continue reading
Cité Radieuse c’est quoi ? Une rencontre, une conversation avec des personnes inspirantes venant d’horizons très divers mais qui ont en commun de faire rayonner une ville : Marseille ! Elles y vivent, y ont vécu ou tout simplement l’aiment pour ce qu’elle a à offrir : Marseille est lumineuse, bouillonnante, arlequinée, agitée, on l’aime autant qu’on la déteste ... parfois ! Parfois seulement ! Je suis Caroline Bindel, journaliste basée à Marseille. Bienvenue dans Cité Radieuse ! Hébergé par ...
…
continue reading
Live/Play Légende des 5 anneaux - une campagne maison dans le settings de Seconde Cité. «C'est rare de trouver des live play avec une campagne étoffée et développée à ce point là J'ai pris un vrai plaisir à l'écouter» Un auditeur: N.L.
…
continue reading
…
continue reading
Experts shape our world. Sometimes for the better, sometimes for the worse. In every big story, you’ll find one; you’ll find a researcher, scientist, engineer, planner, policy wonk, data nerd, bureaucrat, regulator, intellectual, or pseudointellectual. Their ideas are often opaque, unrecognized, and difficult to understand. Some of them like it that way. On Cited, we reveal their hidden stories.
…
continue reading
Le podcast pour une vie plus simple et sereine dans le monde moderne. Minimalisme, slow, écologie, simplicité volontaire...
…
continue reading
Le sacré et la cité tente de répondre à de grandes questions touchant le phénomène religieux dans notre société. Des questions de fond posées avec ouverture et sans complaisance par la communicatrice en histoire Myriam Wojcik. Une série qui vise à briser certains mythes et tabous.
…
continue reading
The Cite Black Women podcast is a periodic program with a simple message: Cite Black Women. We have been producing knowledge since we blessed this earth. We theorize, we innovate, we revolutionize the world. We do not need mediators. We do not need interpreters. It's time to disrupt the canon. It's time to upturn the erasures of history. It's time to give credit where credit is due. This bi-weekly podcast features reflections and conversations about the politics and praxis of acknowledging a ...
…
continue reading
The "Cite of the Crime" Podcast is a biweekly Florida and Federal criminal case law update show for criminal defense attorneys, prosecutors, judges and anybody who is interested in criminal law case law in the Florida District Courts, the Florida Supreme Court, the Eleventh Circuit Court of Appeals and the U.S. Supreme Court. Each week, criminal defense attorney, Jeremy Lasnetski of Shorstein, Lasnetski, & Gihon reviews the previous weeks Florida DCA and Florida Supreme Court cases and in a ...
…
continue reading
1
Ep 91 September 2024 Fourth Circuit Court Update
55:58
55:58
Spill senere
Spill senere
Lister
Lik
Likt
55:58
Jonathan Byrne and Jeremy Thompson of the District of South Carolina Federal Public Defender Office discuss recent Fourth Circuit Court news.
…
continue reading
1
Challenges in the Development and Manufacturing of ADCs
16:24
16:24
Spill senere
Spill senere
Lister
Lik
Likt
16:24
Executive Summary: In this podcast, Andrew Warmington, Manufacturing Editor, Citeline, joins together with industry experts, Simone Secchi, R&D Process Chemist, Olon Group, and Matthieu CULIE, Head of MAB, Pierre Fabre, to discuss the challenges in the development and manufacturing of ADCs.Av Citeline
…
continue reading
1
September 2024 Datamonitor Healthcare Podcast: Radiopharmaceutical Usage is Heating Up
29:56
29:56
Spill senere
Spill senere
Lister
Lik
Likt
29:56
Emma Wille chats with oncology team director Dana Gheorghe, PhD, about the resurgence of radiopharmaceutical therapies in oncology.Other platforms (in addition to SoundCloud):Apple Podcasts - https://podcasts.apple.com/us/podcast/pharma-intelligence-podcasts/id923189836Google Podcasts - https://podcasts.google.com/feed/aHR0cHM6Ly9mZWVkcy5zb3VuZ…
…
continue reading
1
Health-Related Quality of Life Considerations In Clinical Trials
16:44
16:44
Spill senere
Spill senere
Lister
Lik
Likt
16:44
In this podcast, Janelle Hart, Managing Editor at Citeline, teams up with industry experts Mai Yee Mishir, Senior Director of Global Regulatory Affairs, and Sally-Ann McDowell, Senior Director of Clinical Development Strategy at Advanced Clinical, to discuss the vital role of HRQoL in clinical trials. Listen now.…
…
continue reading
1
Over the Counter: Data Tech CEO On Digital Tools Driving Faster, More Sustainable Personal Care
36:37
36:37
Spill senere
Spill senere
Lister
Lik
Likt
36:37
In this episode, HBW chats with Neil D’Souza, CEO of Makersite GmbH, a Stuttgart, Germany-based data software company that offers product data management tools that enable personal care firms to manage product sustainability, cost and compliance. D’Souza provides his take on what defines sustainable product development and how companies can use tec…
…
continue reading
1
Drug Fix: US FDA Worries About Celebs Endorsing Drugs, Post-Chevron Lawsuits Emerging
24:28
24:28
Spill senere
Spill senere
Lister
Lik
Likt
24:28
Introduction: Pink Sheet reporter and editor discuss the FDA’s latest advertising enforcement letter, which targeted a migraine treatment TV commercial featuring Serena Williams, and its impact on drug promotion (:36), as well as the now growing list of legal cases targeting agency decisions with Chevron deference overturned (13:32).More On These T…
…
continue reading
1
September 2024 Datamonitor Healthcare Podcast: Diving into the TME
22:30
22:30
Spill senere
Spill senere
Lister
Lik
Likt
22:30
Emma and Summer meet with oncology analyst Flora to discuss the therapeutic potential of exploring the tumor microenvironment.Apple Podcasts - https://podcasts.apple.com/us/podcast/pharma-intelligence-podcasts/id923189836Google Podcasts - https://podcasts.google.com/feed/aHR0cHM6Ly9mZWVkcy5zb3VuZGNsb3VkLmNvbS91c2Vycy9zb3VuZGNsb3VkOnVzZXJzOjEwNjU…
…
continue reading
1
The Generics Bulletin Podcast: Recent And Upcoming Industry Events
17:14
17:14
Spill senere
Spill senere
Lister
Lik
Likt
17:14
Generics Bulletin's editorial team discusses recent conferences held by Medicines for Europe and the AAM, while looking ahead to the key off-patent industry events on the calendar over the next few months and beyond.Av Citeline
…
continue reading
1
【3分で解説 世界のファーマ】第21回 中国企業 日本で続々治験開始へ (Japanese-language podcast)
3:23
3:23
Spill senere
Spill senere
Lister
Lik
Likt
3:23
世界の製薬ビジネスを伝える「Scrip」と、各国で変化する製薬関連の規制に特化した「Pink Sheet」。普段は英語で発信する2つのオンラインメディアから、今注目の話題を日本語で短くまとめてお届けします。今回取り上げた記事はこちら「Multiple Chinese Firms Expand Global Phase III Trials To Japan(邦訳:中国企業、第三相グローバル治験の地域を続々と日本に拡大)」 https://scrip.citeline.com/SC150842/Multiple-Chinese-Firms-Expand-Global-Phase-III-Trials-To-JapanPlaylist: https://soundcloud.com/citeli…
…
continue reading
1
J&J, '차별화된' 비만 자산에 관심있어 (Korean-language podcast)
3:16
3:16
Spill senere
Spill senere
Lister
Lik
Likt
3:16
호아킨 두아토 존슨앤존슨 대표가 모건스탠리 헬스케어 컨퍼런스에서 발표한 내용입니다.https://scrip.citeline.com/SC150846/JJ-Interested-In-Differentiated-Obesity-AssetsPlaylist: https://soundcloud.com/citelinesounds/sets/korean-language-biopharma-miniAv Citeline
…
continue reading
1
Scrip's Five Must-Know Things - 9 September 2024
14:56
14:56
Spill senere
Spill senere
Lister
Lik
Likt
14:56
Audio roundup of selected biopharma industry content from Scrip over the business week ended 6 September 2024. In this episode: J&J interested in differentiated obesity assets; Kerendia hits in heart failure; strong HERCULES data keep Sanofi’s MS plans alive; WCLC preview; and Mankind sets eyes on 5x growth.https://scrip.citeline.com/SC150865/Quick…
…
continue reading
1
Drug Fix: Pediatric Rare Disease PRV Deadline Approaches, Potential Makena Compounding Ban
34:19
34:19
Spill senere
Spill senere
Lister
Lik
Likt
34:19
Pink Sheet reporter and editors discuss the potential fallout if the US FDA’s rare pediatric disease priority review voucher program is allowed to sunset on 1 October (:30), as well as an upcoming agency advisory committee meeting on potentially banning compounding of the now withdrawn pre-term birth prevention drug Makena (18:39).More On These Top…
…
continue reading
1
Scrip's Five Must-Know Things - 2 September 2024
14:53
14:53
Spill senere
Spill senere
Lister
Lik
Likt
14:53
Audio roundup of selected biopharma industry content from Scrip over the business week ended 30 August 2024. In this episode: summer ADC dealmaking continues apace; a look at cell therapies in Japan; Pfizer’s new US digital consumer platform; Galapagos’s US point of care CAR-T study; and Novartis partners with Lindy on biologics delivery.https://sc…
…
continue reading
1
Drug Fix: New US FDA Developments In AI Regulation
16:59
16:59
Spill senere
Spill senere
Lister
Lik
Likt
16:59
Pink Sheet reporter and editors discuss new developments in the FDA’s plans to regulate artificial intelligence and drugs associated with it, including a new AI Council within CDER, as well as some of the unanswered questions about AI in drug development.More On These Topics From The Pink Sheet Artificial Intelligence: CDER’s New Council Takes Char…
…
continue reading
1
Digital Health Roundup: Digital Therapeutics Navigate GLP-1, Gaming; DHCoE On AI; Hello Heart
13:48
13:48
Spill senere
Spill senere
Lister
Lik
Likt
13:48
In this week’s Digital Health Roundup, Medtech Insight’s Ryan Nelson highlights Click Therapeutics’ FDA-cleared digital therapeutics (DTx) for depression and Sinaptica Therapeutics’ personalized neuromodulation for Alzheimer’s patients. Marion Webb discusses her interview with MindMaze’s John Krakauer on their gaming-focused DTx to help people reco…
…
continue reading
1
Exploring The Postbiotic Opportunity In Consumer Health, With Kerry’s Sonja Nodland
30:48
30:48
Spill senere
Spill senere
Lister
Lik
Likt
30:48
Interest in the human gut microbiome and the influence it exerts on a person’s wellbeing, from cognitive health to immunity, has been rapidly increasing in recent years. In this episode of HBW Insight's Over the Counter podcast we speak to Dublin-based food company Kerry Group about a particularly exciting, emerging area of microbiome-based wellnes…
…
continue reading
1
Scrip's Five Must-Know Things - 26 August 2024
14:15
14:15
Spill senere
Spill senere
Lister
Lik
Likt
14:15
Audio roundup of selected biopharma industry content from Scrip over the business week ended 23 August 2024. In this episode: CMS’s price reveal better than expected?; new diabetes risk data for Zepbound; can J&J’s lung cancer combo stand up to Tagrisso?; new recruits for BioMarin leadership; and Glenmark’s shifting revenues.https://scrip.citeline.…
…
continue reading
1
Ep 90 August 2024 Part 2 of 2 Fourth Circuit Court Update
26:24
26:24
Spill senere
Spill senere
Lister
Lik
Likt
26:24
Jonathan Byrne and Jackie Tarlton of the Eastern District of North Carolina Federal Public Defender Office discuss recent Fourth Circuit Court news.
…
continue reading
1
August 2024 Datamonitor Healthcare Podcast: The Colorful Landscape of Therapeutic Psychedelics
15:22
15:22
Spill senere
Spill senere
Lister
Lik
Likt
15:22
Following the recent FDA rejection of MDMA therapy for PTSD, Emma and Flora discuss the future role of psychedelics in the treatment of mental health disorders. Content warning: This episode does contain mentions of sexual assault and abuse.Apple Podcasts - https://podcasts.apple.com/us/podcast/pharma-intelligence-podcasts/id923189836Google Podcas…
…
continue reading
1
Ep 89 August 2024 Part 1 of 2 Supreme Court Update
34:34
34:34
Spill senere
Spill senere
Lister
Lik
Likt
34:34
Jonathan Byrne and Jackie Tarlton of the Eastern District of North Carolina Federal Public Defender Office discuss recent Supreme Court news.
…
continue reading
1
Episode #7: The (ir)Rational Alaskans (pt. 3 of 3)
1:07:07
1:07:07
Spill senere
Spill senere
Lister
Lik
Likt
1:07:07
In the last episode of the (ir)Rational Alaskans, Riki Ott, Linden O’Toole, and thousands of other Alaskan fishers won over $5 billion in punitive damages against Exxon for the Exxon Valdez oil spill. In our finale, while Ott and O’Toole wait for their cheques, Exxon fights back with a legal and academic appeal. In that appeal, they marshal the mos…
…
continue reading
1
Bioprinting – An Innovative Tool That Is Revolutionizing Drug Discovery
41:14
41:14
Spill senere
Spill senere
Lister
Lik
Likt
41:14
Keith Murphy, co-founder of Organovo, discusses the growing potential of bioprinting and how the company is using its technologies to study and develop treatments for inflammatory bowel disease (IBD).Av Citeline
…
continue reading
1
Scrip's Five Must-Know Things - 19 August 2024
15:10
15:10
Spill senere
Spill senere
Lister
Lik
Likt
15:10
Audio roundup of selected biopharma industry content from Scrip over the business week ended 16 August 2024. In this episode: Merck & Co. steps into CD19 bispecific space; gene therapy patients rise, but slowly; Madrigal’s Rezdiffra plans; Korean biopharma financing recovering?; and approvals to watch out for in Q3.https://scrip.citeline.com/SC1507…
…
continue reading
1
Drug Fix: What We Learned From The First Batch Of Medicare Negotiated Drug Prices
35:44
35:44
Spill senere
Spill senere
Lister
Lik
Likt
35:44
Pink Sheet reporter and editors discuss the take-aways from the landmark first Medicare negotiated drug prices and what additional information remains outstanding.More On These Topics From The Pink SheetMedicare Negotiation Announcement: Discounts From List Price Up To 79%, But Net Savings Unclear: https://pink.citeline.com/PS155128/Medicare-Negoti…
…
continue reading
Au coeur de l'été j'ai eu envie de vous offrir un moment easy listening, une compil de moments de Cité Radieuse mêlés à des sons qui sentent bon le soleil, le bleu de la mer et la minéralité de Marseille ! C'est une première, j'espère que ça vous plaira ! Hébergé par Ausha. Visitez ausha.co/politique-de-confidentialite pour plus d'informations.…
…
continue reading
1
【3分で解説 世界のファーマ】第20回 欧州心臓病学会 注目の新薬候補は (Japanese-language podcast)
3:03
3:03
Spill senere
Spill senere
Lister
Lik
Likt
3:03
世界の製薬ビジネスを伝える「Scrip」と、各国で変化する製薬関連の規制に特化した「Pink Sheet」。普段は英語で発信する2つのオンラインメディアから、今注目の話題を日本語で短くまとめてお届けします。今回取り上げた記事はこちらWhat To Look Out For At ESC 2024https://scrip.citeline.com/SC150740/What-To-Look-Out-For-At-ESC-2024Av Citeline
…
continue reading
1
Sustainable By Design: Thermo Fisher's Meron Mathias On ESG Compliance And The Competitive Edge
29:47
29:47
Spill senere
Spill senere
Lister
Lik
Likt
29:47
Compliance with environmental sustainability goals is no longer optional for medtech companies serving global healthcare markets. Thermo Fisher has made it a mission to be a leader in thought and actions in meeting Scope 1, 2 and 3 needs. Corporate VP and head of sustainability Meron Mathias explains the company's sustainability aims and methods, f…
…
continue reading
1
Episode #6: The (ir)Rational Alaskans (pt. 2 of 3)
1:06:04
1:06:04
Spill senere
Spill senere
Lister
Lik
Likt
1:06:04
Last episode, the Exxon Valdez oil spill devastates Cordova, Alaska. In this second part, 12 Angry Alaskans, a jury of ordinary Alaskans picks up our story. They muddle through the most devastating, and most complicated, environmental disaster in US history. How would they decide the case? You can listen to a trailer of the next week’s episode, Dam…
…
continue reading
1
Scrip's Five Must-Know Things - 13 August 2024
15:29
15:29
Spill senere
Spill senere
Lister
Lik
Likt
15:29
Audio roundup of selected biopharma industry content from Scrip over the business week ended 9 August 2024. In this episode: Amgen positions for obesity and diabetes; BMS returns TIGIT asset in pipeline reshuffle; is Kerendia the next jewel in Bayer’s crown?; Japan pharma firms cut jobs; and Sun Pharma seeks GLP-1 partner.https://scrip.citeline.com…
…
continue reading
1
11.08.2024 - Croire Dieu(Frederic Dalais)
41:53
41:53
Spill senere
Spill senere
Lister
Lik
Likt
41:53
11.08.2024 - Croire Dieu(Frederic Dalais) by La CitéAv La Cité
…
continue reading
1
04.08.2024 - Marcher avec Dieu(Frederic Dalais)
45:02
45:02
Spill senere
Spill senere
Lister
Lik
Likt
45:02
04.08.2024 - Marcher avec Dieu(Frederic Dalais) by La CitéAv La Cité
…
continue reading
1
28.07.2024 - Courons la Course(Daniel Dalais)
30:50
30:50
Spill senere
Spill senere
Lister
Lik
Likt
30:50
28.07.2024 - Courons la Course(Daniel Dalais) by La CitéAv La Cité
…
continue reading
1
21.07.2024 - Psaume 46 - Comment Trouver le Repos(Nathanael Westphal)
40:19
40:19
Spill senere
Spill senere
Lister
Lik
Likt
40:19
21.07.2024 - Psaume 46 - Comment Trouver le Repos(Nathanael Westphal) by La CitéAv La Cité
…
continue reading
1
14.07.2024 - Nos Bénédictions(Olivier Corimbelly)
39:58
39:58
Spill senere
Spill senere
Lister
Lik
Likt
39:58
14.07.2024 - Nos Bénédictions(Olivier Corimbelly) by La CitéAv La Cité
…
continue reading
1
07.07.2024 - La Générosité(Simona Vilcu)
41:59
41:59
Spill senere
Spill senere
Lister
Lik
Likt
41:59
07.07.2024 - La Générosité(Simona Vilcu) by La CitéAv La Cité
…
continue reading
1
30.06.2024 - Jean 17:20-26(Frederic Dalais)
43:29
43:29
Spill senere
Spill senere
Lister
Lik
Likt
43:29
30.06.2024 - Jean 17:20-26(Frederic Dalais) by La CitéAv La Cité
…
continue reading
1
23.06.2024 - Jean 17:6-19(Frederic Dalais)
46:58
46:58
Spill senere
Spill senere
Lister
Lik
Likt
46:58
23.06.2024 - Jean 17:6-19(Frederic Dalais) by La CitéAv La Cité
…
continue reading
1
16.06.2024 - Jean 17:1-5(Frederic Dalais)
40:59
40:59
Spill senere
Spill senere
Lister
Lik
Likt
40:59
16.06.2024 - Jean 17:1-5(Frederic Dalais) by La CitéAv La Cité
…
continue reading
1
02.06.2024 - Jean 16:16-33 - Une Perspective du Ciel(Frederic Dalais)
37:44
37:44
Spill senere
Spill senere
Lister
Lik
Likt
37:44
02.06.2024 - Jean 16:16-33 - Une Perspective du Ciel(Frederic Dalais) by La CitéAv La Cité
…
continue reading
1
26.05.2024 - Message Apostolique(Craig Meyer)
42:51
42:51
Spill senere
Spill senere
Lister
Lik
Likt
42:51
26.05.2024 - Message Apostolique(Craig Meyer) by La CitéAv La Cité
…
continue reading
1
19.05.2024 - Hebreux 12:1-2(Frederic Dalais)
44:25
44:25
Spill senere
Spill senere
Lister
Lik
Likt
44:25
19.05.2024 - Hebreux 12:1-2(Frederic Dalais) by La CitéAv La Cité
…
continue reading
1
12.05.2024 - Le Royaume de Dieu(Tim Williams)
36:46
36:46
Spill senere
Spill senere
Lister
Lik
Likt
36:46
12.05.2024 - Le Royaume de Dieu(Tim Williams) by La CitéAv La Cité
…
continue reading
1
05.05.2024 - Message Apostolique(Steve Sudworth)
33:37
33:37
Spill senere
Spill senere
Lister
Lik
Likt
33:37
05.05.2024 - Message Apostolique(Steve Sudworth) by La CitéAv La Cité
…
continue reading
1
Why Purpose Is Key To Driving CHC Growth, With Haleon’s Bas Vorsteveld
40:19
40:19
Spill senere
Spill senere
Lister
Lik
Likt
40:19
Since becoming a standalone consumer health company, Haleon has been driving awareness of public health issues such as chronic pain and children’s oral health. In this episode of Over the Counter, HBW Insight catches up with Haleon vice president and general manager Great Britain and Ireland Bas Vorsteveld, to find out more about why having a purpo…
…
continue reading
1
Drug Fix: Clinical Trial Diversity, Off-Label Standard Of Care Issues, In-Person US FDA Adcomms
33:10
33:10
Spill senere
Spill senere
Lister
Lik
Likt
33:10
Pink Sheet reporter and editors discuss former Surgeon General Jerome Adams’ views on how the FDA can better ensure clinical trial diversity (:27), questions about approving a new drug that would be used with a standard of care regimen that is off-label (15:00), and the agency beginning to schedule fully in-person advisory committee meetings (24:03…
…
continue reading
In this audio, Dr. Anthony Fritz discusses Type 2 diabetes and the benefits of SGLT2 inhibitors. Learn how this treatment option can improve diabetes care.Av Citeline
…
continue reading
1
Episode #5: The (ir)Rational Alaskans (pt. 1 of 3)
59:33
59:33
Spill senere
Spill senere
Lister
Lik
Likt
59:33
After the unprecedented Exxon Valdez oil spill, a jury of ordinary Alaskans decided that Exxon had to be punished. However, Exxon fought back against their punishment. They did so, in-part, by supporting research that suggested jurors are irrational. This work came from an esteemed group of psychologists, behavioural economists, and legal theorists…
…
continue reading
1
비만치료제, 2024년 상반기 대형주를 지배하다 (Korean-language podcast)
3:24
3:24
Spill senere
Spill senere
Lister
Lik
Likt
3:24
올해 상반기 일라이 릴리와 노보 노디스크의 주가가 가장 높은 상승세를 보인 반면, BMS와 길리어드의 주가는 가장 큰 폭으로 하락했습니다. Scrip의 글로벌 제약주 동향 기사를 요약한 내용입니다.https://scrip.citeline.com/SC150593/Obesity-Rules-Large-Cap-Stocks-In-First-Half-Of-2024Av Citeline
…
continue reading
1
Scrip's Five Must-Know Things - 5 August 2024
15:19
15:19
Spill senere
Spill senere
Lister
Lik
Likt
15:19
Audio roundup of selected biopharma industry content from Scrip over the business week ended 2 August 2024. In this episode: Pfizer bullish on its oral GLP-1; BMS’s rising confidence about Medicare pricing of Eliquis; more long term data for Leqembi; NewAmsterdam’s CETP inhibitor shows promise; and a look at Mankind’s Bharat Serums buy.https://scri…
…
continue reading
1
Drug Fix: August User Fee Goals, Oncology Trial Design Issues, EMA Review Changes
38:50
38:50
Spill senere
Spill senere
Lister
Lik
Likt
38:50
Pink Sheet reporter and editors discuss the US FDA drug approval decisions that could arrive in August (:34), a trial design issue that could ensnare BMS’ Opdivo along with AstraZeneca’s Imfinzi (10:11), and the EMA potentially asking all sponsors to provide raw clinical data as part of application reviews (33:14).More On These Topics From The Pink…
…
continue reading